A Study Evaluating DS-1055a in Participants With Relapsed or Refractory Locally Advanced or Metastatic Solid Tumors

NCT04419532 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor
Advanced Cancer
Metastatic Solid Tumor

Interventions

DRUG: DS-1055a

Sponsor

Daiichi Sankyo